Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/30/09 → 10/30/10 |
Funding
- Bayer Healthcare Pharmaceuticals Incorporated: $4,812.63
MAGELLAN-Multicenter, Randomized, Parallel Group Efficacy and Safety Study for Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients Comparing Rivaroxaan with Enoxaparin
- Landau, David (CoPI)
- Tassiopoulos, Apostolos (CoPI)
- Gasparis, Antonios (PI)
Project: Research